Abstract
The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.
MeSH terms
-
Antitubercular Agents / administration & dosage
-
Antitubercular Agents / therapeutic use*
-
Clinical Trials as Topic* / economics
-
Clinical Trials as Topic* / methods
-
Drug Therapy, Combination
-
Humans
-
Mycobacterium tuberculosis
-
Tuberculosis / drug therapy*
-
Tuberculosis / microbiology
-
Tuberculosis, Multidrug-Resistant / drug therapy*
-
Tuberculosis, Multidrug-Resistant / microbiology